MAPT and Alzheimer disease: In these mice, an elevation in the level of phosphorylated tau, typically seen in the APP/PS1 mice, was attenuated in the absence of Mif. This result provides additional evidence for a role of MIF in tau hyperphosphorylation in the AD mouse.